Use of a Serum/Glucocorticoid-regulated kinase

Details for Australian Patent Application No. 2005313576 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Dietz, Uwe; Bartnik, Eckart; Brimmer, Annette; Aigner, Thomas

Agent Watermark

Pub. Number AU-B-2005313576

PCT Pub. Number WO2006/061130

Priority 10 2004 059 781.2 10.12.04 DE

Filing date 1 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 17 November 2011

International Classifications

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/061130 Priority application(s): WO2006/061130

17 November 2011 Application Accepted

  Published as AU-B-2005313576

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313581-Phenyl-piperazin methanone derivatives

2005313575-Production of a resin-impregnated fiber tube for internally lining conduits and pipes or pipe systems